APO Research
Talk to an analyst

APO RESEARCH · REPORT

Human Immunodeficiency Virus Type-1

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Human Immunodeficiency Virus Type-1 Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

27 December 2025199 pages

Choose your research edition.

Industry ResearchHuman Immunodeficiency Virus Type-1 Industry Research Report 2026124 pages · $2,950 USDIndustry Growth & TrendsGlobal Human Immunodeficiency Virus Type-1 Industry Growth and Trends Forecast to 2032100 pages · $3,450 USDMarket StructureGlobal Human Immunodeficiency Virus Type-1 Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032199 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Human Immunodeficiency Virus Type-1 Market Outlook and Growth Opportunities 2026197 pages · $4,250 USDMarket Analysis & ForecastGlobal Human Immunodeficiency Virus Type-1 Market Analysis and Forecast 2026-2032191 pages · $4,950 USD

Market perspective

The global Human Immunodeficiency Virus Type-1 market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The US & Canada market for Human Immunodeficiency Virus Type-1 is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Human Immunodeficiency Virus Type-1 is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Human Immunodeficiency Virus Type-1 is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Human Immunodeficiency Virus Type-1 is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Human Immunodeficiency Virus Type-1 include AstraZeneca, Bayer, Bristol Myers Squibb, Merck & Co. Inc., Novartis, Pfizer, Viatris, GSK and Roche, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Includes

This report provides an overview of the global Human Immunodeficiency Virus Type-1 market and its size, analyzing global market trends based on historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Human Immunodeficiency Virus Type-1 and revenue in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Human Immunodeficiency Virus Type-1 revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering revenue and growth rates—for 2021-2032, and evaluates and forecasts the Human Immunodeficiency Virus Type-1 market size, projected growth trends, production technologies, key applications, and end-use industries.

Human Immunodeficiency Virus Type-1 Segment by Company

AstraZeneca

Bayer

Bristol Myers Squibb

Merck & Co. Inc.

Novartis

Pfizer

Viatris

GSK

Roche

Sanofi

Human Immunodeficiency Virus Type-1 Segment by Type

Integrase Inhibitor

Nucleoside and Nucleotide Reverse Transcriptase Inhibitors (NRTIs)

Non-nucleoside Reverse Transcriptase Inhibitors (NNRTIs)

Protease Inhibitors (PIs)

Others

Human Immunodeficiency Virus Type-1 Segment by Application

Retail Pharmacies

Hospital Pharmacies

Human Immunodeficiency Virus Type-1 Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Human Immunodeficiency Virus Type-1 market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Human Immunodeficiency Virus Type-1 and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Human Immunodeficiency Virus Type-1.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. Revenue of Human Immunodeficiency Virus Type-1 in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Human Immunodeficiency Virus Type-1 industry.

Chapter 3: Detailed analysis of Human Immunodeficiency Virus Type-1 companies' competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Human Immunodeficiency Virus Type-1revenue, gross margin, and recent development, etc.

Chapter 7: North America (US & Canada) by type, by application and by country, revenue for each segment.

Chapter 8: Europe by type, by application and by country, revenue for each segment.

Chapter 9: China by type, and by application, revenue for each segment.

Chapter 10: Asia (excluding China) by type, by application and by region, revenue for each segment.

Chapter 11: South America, Middle East & Africa by type, by application and by country, revenue for each segment.

Chapter 12: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Human Immunodeficiency Virus Type-1 Market Size Growth Rate by Type (US$ Million): 2021 VS 2025 VS 2032 Table 2. Key Players of Integrase Inhibitor Table 3. Key Players of Nucleoside and Nucleotide Reverse Transcriptase Inhibitors (NRTIs) Table 4. Key Players of Non-nucleoside Reverse Transcriptase Inhibitors (NNRTIs) Table 3. Key Players of Protease Inhibitors (PIs) Table 4. Key Players of Others Table 5. Global Human Immunodeficiency Virus Type-1 Market Size Growth Rate by Application (US$ Million): 2021 VS 2025 VS 2032 Table 6. Key Players of Retail Pharmacies Table 7. Key Players of Hospital Pharmacies Table 8. Global Human Immunodeficiency Virus Type-1 Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 9. Global Human Immunodeficiency Virus Type-1 Market Size by Region (2021-2026) & (US$ Million) Table 10. Global Human Immunodeficiency Virus Type-1 Market Share by Region (2021-2026) Table 11. Global Human Immunodeficiency Virus Type-1 Market Size by Region (2027-2032) & (US$ Million) Table 12. Global Human Immunodeficiency Virus Type-1 Market Share by Region (2027-2032) Table 13. Human Immunodeficiency Virus Type-1 Industry Trends Table 14. Human Immunodeficiency Virus Type-1 Industry Drivers Table 15. Human Immunodeficiency Virus Type-1 Industry Opportunities and Challenges Table 16. Human Immunodeficiency Virus Type-1 Industry Restraints Table 17. Global Human Immunodeficiency Virus Type-1 Revenue by Company (US$ Million) & (2021-2026) Table 18. Global Human Immunodeficiency Virus Type-1 Revenue Market Share by Company (2021-2026) Table 19. Global Human Immunodeficiency Virus Type-1 Players Revenue Ranking, 2024 VS 2025 VS 2026 Table 20. Global Human Immunodeficiency Virus Type-1 Key Company Head Office and Area Served Table 21. Global Human Immunodeficiency Virus Type-1 Company, Product Type & Application Table 22. Global Human Immunodeficiency Virus Type-1 Company Establishment Date Table 23. Global Company Market Concentration Ratio (CR5 and HHI) Table 24. Global Human Immunodeficiency Virus Type-1 by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 25. Global Human Immunodeficiency Virus Type-1 Market Size by Type 2021 VS 2025 VS 2032 (US$ Million) Table 26. Global Human Immunodeficiency Virus Type-1 Market Size by Type (2021-2026) & (US$ Million) Table 27. Global Human Immunodeficiency Virus Type-1 Market Size by Type (2027-2032) & (US$ Million) Table 28. Global Human Immunodeficiency Virus Type-1 Revenue Market Share by Type (2021-2026) Table 29. Global Human Immunodeficiency Virus Type-1 Revenue Market Share by Type (2027-2032) Table 30. Global Human Immunodeficiency Virus Type-1 Market Size by Application 2021 VS 2025 VS 2032 (US$ Million) Table 31. Global Human Immunodeficiency Virus Type-1 Market Size by Application (2021-2026) & (US$ Million) Table 32. Global Human Immunodeficiency Virus Type-1 Market Size by Application (2027-2032) & (US$ Million) Table 33. Global Human Immunodeficiency Virus Type-1 Revenue Market Share by Application (2021-2026) Table 34. Global Human Immunodeficiency Virus Type-1 Revenue Market Share by Application (2027-2032) Table 35. AstraZeneca Company Information Table 36. AstraZeneca Business Overview Table 37. AstraZeneca Human Immunodeficiency Virus Type-1 Revenue and Gross Margin (US$ Million) & (2021-2026) Table 38. AstraZeneca Human Immunodeficiency Virus Type-1 Product Portfolio Table 39. AstraZeneca Recent Development Table 40. Bayer Company Information Table 41. Bayer Business Overview Table 42. Bayer Human Immunodeficiency Virus Type-1 Revenue and Gross Margin (US$ Million) & (2021-2026) Table 43. Bayer Human Immunodeficiency Virus Type-1 Product Portfolio Table 44. Bayer Recent Development Table 45. Bristol Myers Squibb Company Information Table 46. Bristol Myers Squibb Business Overview Table 47. Bristol Myers Squibb Human Immunodeficiency Virus Type-1 Revenue and Gross Margin (US$ Million) & (2021-2026) Table 48. Bristol Myers Squibb Human Immunodeficiency Virus Type-1 Product Portfolio Table 49. Bristol Myers Squibb Recent Development Table 50. Merck & Co. Inc. Company Information Table 51. Merck & Co. Inc. Business Overview Table 52. Merck & Co. Inc. Human Immunodeficiency Virus Type-1 Revenue and Gross Margin (US$ Million) & (2021-2026) Table 53. Merck & Co. Inc. Human Immunodeficiency Virus Type-1 Product Portfolio Table 54. Merck & Co. Inc. Recent Development Table 55. Novartis Company Information Table 56. Novartis Business Overview Table 57. Novartis Human Immunodeficiency Virus Type-1 Revenue and Gross Margin (US$ Million) & (2021-2026) Table 58. Novartis Human Immunodeficiency Virus Type-1 Product Portfolio Table 59. Novartis Recent Development Table 60. Pfizer Company Information Table 61. Pfizer Business Overview Table 62. Pfizer Human Immunodeficiency Virus Type-1 Revenue and Gross Margin (US$ Million) & (2021-2026) Table 63. Pfizer Human Immunodeficiency Virus Type-1 Product Portfolio Table 64. Pfizer Recent Development Table 65. Viatris Company Information Table 66. Viatris Business Overview Table 67. Viatris Human Immunodeficiency Virus Type-1 Revenue and Gross Margin (US$ Million) & (2021-2026) Table 68. Viatris Human Immunodeficiency Virus Type-1 Product Portfolio Table 69. Viatris Recent Development Table 70. GSK Company Information Table 71. GSK Business Overview Table 72. GSK Human Immunodeficiency Virus Type-1 Revenue and Gross Margin (US$ Million) & (2021-2026) Table 73. GSK Human Immunodeficiency Virus Type-1 Product Portfolio Table 74. GSK Recent Development Table 75. Roche Company Information Table 76. Roche Business Overview Table 77. Roche Human Immunodeficiency Virus Type-1 Revenue and Gross Margin (US$ Million) & (2021-2026) Table 78. Roche Human Immunodeficiency Virus Type-1 Product Portfolio Table 79. Roche Recent Development Table 80. Sanofi Company Information Table 81. Sanofi Business Overview Table 82. Sanofi Human Immunodeficiency Virus Type-1 Revenue and Gross Margin (US$ Million) & (2021-2026) Table 83. Sanofi Human Immunodeficiency Virus Type-1 Product Portfolio Table 84. Sanofi Recent Development Table 85. North America Human Immunodeficiency Virus Type-1 Market Size by Type (2021-2026) & (US$ Million) Table 86. North America Human Immunodeficiency Virus Type-1 Market Size by Type (2027-2032) & (US$ Million) Table 87. North America Human Immunodeficiency Virus Type-1 Market Size by Application (2021-2026) & (US$ Million) Table 88. North America Human Immunodeficiency Virus Type-1 Market Size by Application (2027-2032) & (US$ Million) Table 89. North America Human Immunodeficiency Virus Type-1 Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 90. North America Human Immunodeficiency Virus Type-1 Market Size by Country (2021-2026) Table 91. North America Human Immunodeficiency Virus Type-1 Market Size by Country (2027-2032) Table 92. Europe Human Immunodeficiency Virus Type-1 Market Size by Type (2021-2026) & (US$ Million) Table 93. Europe Human Immunodeficiency Virus Type-1 Market Size by Type (2027-2032) & (US$ Million) Table 94. Europe Human Immunodeficiency Virus Type-1 Market Size by Application (2021-2026) & (US$ Million) Table 95. Europe Human Immunodeficiency Virus Type-1 Market Size by Application (2027-2032) & (US$ Million) Table 96. Europe Human Immunodeficiency Virus Type-1 Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 97. Europe Human Immunodeficiency Virus Type-1 Market Size by Country (2021-2026) Table 98. Europe Human Immunodeficiency Virus Type-1 Market Size by Country (2027-2032) Table 99. China Human Immunodeficiency Virus Type-1 Market Size by Type (2021-2026) & (US$ Million) Table 100. China Human Immunodeficiency Virus Type-1 Market Size by Type (2027-2032) & (US$ Million) Table 101. China Human Immunodeficiency Virus Type-1 Market Size by Application (2021-2026) & (US$ Million) Table 102. China Human Immunodeficiency Virus Type-1 Market Size by Application (2027-2032) & (US$ Million) Table 103. Asia Human Immunodeficiency Virus Type-1 Market Size by Type (2021-2026) & (US$ Million) Table 104. Asia Human Immunodeficiency Virus Type-1 Market Size by Type (2027-2032) & (US$ Million) Table 105. Asia Human Immunodeficiency Virus Type-1 Market Size by Application (2021-2026) & (US$ Million) Table 106. Asia Human Immunodeficiency Virus Type-1 Market Size by Application (2027-2032) & (US$ Million) Table 107. Asia Human Immunodeficiency Virus Type-1 Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 108. Asia Human Immunodeficiency Virus Type-1 Market Size by Country (2021-2026) Table 109. Asia Human Immunodeficiency Virus Type-1 Market Size by Country (2027-2032) Table 110. South America, Middle East & Africa Human Immunodeficiency Virus Type-1 Market Size by Type (2021-2026) & (US$ Million) Table 111. South America, Middle East & Africa Human Immunodeficiency Virus Type-1 Market Size by Type (2027-2032) & (US$ Million) Table 112. South America, Middle East & Africa Human Immunodeficiency Virus Type-1 Market Size by Application (2021-2026) & (US$ Million) Table 113. South America, Middle East & Africa Human Immunodeficiency Virus Type-1 Market Size by Application (2027-2032) & (US$ Million) Table 114. South America, Middle East & Africa Human Immunodeficiency Virus Type-1 Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 115. South America, Middle East & Africa Human Immunodeficiency Virus Type-1 Market Size by Country (2021-2026) Table 116. South America, Middle East & Africa Human Immunodeficiency Virus Type-1 Market Size by Country (2027-2032) Table 117. Research Programs/Design for This Report Table 118. Authors List of This Report Table 119. Secondary Sources Table 120. Primary Sources List of Figures Figure 1. Human Immunodeficiency Virus Type-1 Product Image Figure 2. Global Human Immunodeficiency Virus Type-1 Market Size Growth Rate by Type, 2021 VS 2025 VS 2032 (US$ Million) Figure 3. Global Human Immunodeficiency Virus Type-1 Market Share by Type: 2025 VS 2032 Figure 4. Integrase Inhibitor Image Figure 5. Nucleoside and Nucleotide Reverse Transcriptase Inhibitors (NRTIs) Image Figure 6. Non-nucleoside Reverse Transcriptase Inhibitors (NNRTIs) Image Figure 7. Protease Inhibitors (PIs) Image Figure 8. Others Image Figure 9. Global Human Immunodeficiency Virus Type-1 Market Size Growth Rate by Application, 2021 VS 2025 VS 2032 (US$ Million) Figure 10. Global Human Immunodeficiency Virus Type-1 Market Share by Application: 2025 VS 2032 Figure 11. Retail Pharmacies Image Figure 12. Hospital Pharmacies Image Figure 13. Global Human Immunodeficiency Virus Type-1 Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 14. Global Human Immunodeficiency Virus Type-1 Market Size (2021-2032) & (US$ Million) Figure 15. Global Human Immunodeficiency Virus Type-1 Market Share by Region: 2025 VS 2032 Figure 16. Years Considered Figure 17. Global Human Immunodeficiency Virus Type-1 Market Share by Players in 2025 Figure 18. Global Top 5 and 10 Human Immunodeficiency Virus Type-1 Players Market Share by Revenue in 2025 Figure 19. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 20. Global Human Immunodeficiency Virus Type-1 Market Size by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 21. Global Human Immunodeficiency Virus Type-1 Revenue Market Share by Type (2021-2032) Figure 22. Global Human Immunodeficiency Virus Type-1 Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 23. Global Human Immunodeficiency Virus Type-1 Revenue Market Share by Application (2021-2032) Figure 24. North America Human Immunodeficiency Virus Type-1 Market Size (2021-2032) & (US$ Million) Figure 25. North America Human Immunodeficiency Virus Type-1 Market Share by Type (2021-2032) Figure 26. North America Human Immunodeficiency Virus Type-1 Market Share by Application (2021-2032) Figure 27. North America Human Immunodeficiency Virus Type-1 Market Share by Country (2021-2032) Figure 28. United States Human Immunodeficiency Virus Type-1 Market Size (2021-2032) & (US$ Million) Figure 29. Canada Human Immunodeficiency Virus Type-1 Market Size (2021-2032) & (US$ Million) Figure 30. Mexico Human Immunodeficiency Virus Type-1 Market Size (2021-2032) & (US$ Million) Figure 31. Europe Human Immunodeficiency Virus Type-1 Market Size (2021-2032) & (US$ Million) Figure 32. Europe Human Immunodeficiency Virus Type-1 Market Share by Type (2021-2032) Figure 33. Europe Human Immunodeficiency Virus Type-1 Market Share by Application (2021-2032) Figure 34. Europe Human Immunodeficiency Virus Type-1 Market Share by Country (2021-2032) Figure 35. Germany Human Immunodeficiency Virus Type-1 Market Size (2021-2032) & (US$ Million) Figure 36. France Human Immunodeficiency Virus Type-1 Market Size (2021-2032) & (US$ Million) Figure 37. U.K. Human Immunodeficiency Virus Type-1 Market Size (2021-2032) & (US$ Million) Figure 38. Italy Human Immunodeficiency Virus Type-1 Market Size (2021-2032) & (US$ Million) Figure 39. Russia Human Immunodeficiency Virus Type-1 Market Size (2021-2032) & (US$ Million) Figure 40. Nordic Countries Human Immunodeficiency Virus Type-1 Market Size (2021-2032) & (US$ Million) Figure 41. China Human Immunodeficiency Virus Type-1 Market Size (2021-2032) & (US$ Million) Figure 42. China Human Immunodeficiency Virus Type-1 Market Share by Type (2021-2032) Figure 43. China Human Immunodeficiency Virus Type-1 Market Share by Application (2021-2032) Figure 44. Asia Human Immunodeficiency Virus Type-1 Market Size (2021-2032) & (US$ Million) Figure 45. Asia Human Immunodeficiency Virus Type-1 Market Share by Type (2021-2032) Figure 46. Asia Human Immunodeficiency Virus Type-1 Market Share by Application (2021-2032) Figure 47. Asia Human Immunodeficiency Virus Type-1 Market Share by Country (2021-2032) Figure 48. Japan Human Immunodeficiency Virus Type-1 Market Size (2021-2032) & (US$ Million) Figure 49. South Korea Human Immunodeficiency Virus Type-1 Market Size (2021-2032) & (US$ Million) Figure 50. Taiwan Human Immunodeficiency Virus Type-1 Market Size (2021-2032) & (US$ Million) Figure 51. Southeast Asia Human Immunodeficiency Virus Type-1 Market Size (2021-2032) & (US$ Million) Figure 52. India Human Immunodeficiency Virus Type-1 Market Size (2021-2032) & (US$ Million) Figure 53. Australia Human Immunodeficiency Virus Type-1 Market Size (2021-2032) & (US$ Million) Figure 54. South America, Middle East & Africa Human Immunodeficiency Virus Type-1 Market Size (2021-2032) & (US$ Million) Figure 55. South America, Middle East & Africa Human Immunodeficiency Virus Type-1 Market Share by Type (2021-2032) Figure 56. South America, Middle East & Africa Human Immunodeficiency Virus Type-1 Market Share by Application (2021-2032) Figure 57. South America, Middle East & Africa Human Immunodeficiency Virus Type-1 Market Share by Country (2021-2032) Figure 58. Brazil Human Immunodeficiency Virus Type-1 Market Size (2021-2032) & (US$ Million) Figure 59. South Africa Human Immunodeficiency Virus Type-1 Market Size (2021-2032) & (US$ Million) Figure 60. Saudi Arabia Human Immunodeficiency Virus Type-1 Market Size (2021-2032) & (US$ Million) Figure 61. Turkey Human Immunodeficiency Virus Type-1 Market Size (2021-2032) & (US$ Million) Figure 62. Argentina Human Immunodeficiency Virus Type-1 Market Size (2021-2032) & (US$ Million) Figure 63. UAE Human Immunodeficiency Virus Type-1 Market Size (2021-2032) & (US$ Million) Figure 64. Egypt Human Immunodeficiency Virus Type-1 Market Size (2021-2032) & (US$ Million) Figure 65. Chile Human Immunodeficiency Virus Type-1 Market Size (2021-2032) & (US$ Million) Figure 66. Research Process Figure 67. Key Executives Interviewed

Scope & coverage.

Types
  • Integrase Inhibitor
  • Nucleoside and Nucleotide Reverse Transcriptase Inhibitors (NRTIs)
  • Non-nucleoside Reverse Transcriptase Inhibitors (NNRTIs)
  • Protease Inhibitors (PIs)
  • Others
Applications
  • Retail Pharmacies
  • Hospital Pharmacies
Companies covered
  • AstraZeneca
  • Bayer
  • Bristol Myers Squibb
  • Merck & Co. Inc.
  • Novartis
  • Pfizer
  • Viatris
  • GSK
  • Roche
  • Sanofi

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Market Analysis by Type
  3. 1.2.1 Global Human Immunodeficiency Virus Type-1 Market Size Growth Rate by Type: 2021 VS 2025 VS 2032
  4. 1.2.2 Integrase Inhibitor
  5. 1.2.3 Nucleoside and Nucleotide Reverse Transcriptase Inhibitors (NRTIs)
  6. 1.2.4 Non-nucleoside Reverse Transcriptase Inhibitors (NNRTIs)
  7. 1.2.5 Protease Inhibitors (PIs)
  8. 1.2.6 Others
  9. 1.3 Market Analysis by Application
  10. 1.3.1 Global Human Immunodeficiency Virus Type-1 Market Size Growth Rate by Application: 2021 VS 2025 VS 2032
  11. 1.3.2 Retail Pharmacies
  12. 1.3.3 Hospital Pharmacies
  13. 1.4 Global Market Growth Prospects
  14. 1.5 Global Human Immunodeficiency Virus Type-1 Growth Trends by Region
  15. 1.5.1 Global Human Immunodeficiency Virus Type-1 Market Size by Region: 2021 VS 2025 VS 2032
  16. 1.5.2 Human Immunodeficiency Virus Type-1 Market Size by Region (2021-2026)
  17. 1.5.3 Human Immunodeficiency Virus Type-1 Market Size by Region (2027-2032)
  18. 1.6 Assumptions and Limitations
  19. 1.7 Study Goals and Objectives
  20. 1.8 Years Considered
2 Global Human Immunodeficiency Virus Type-1 Market Dynamics
  1. 2.1 Human Immunodeficiency Virus Type-1 Industry Trends
  2. 2.2 Human Immunodeficiency Virus Type-1 Industry Drivers
  3. 2.3 Human Immunodeficiency Virus Type-1 Industry Opportunities and Challenges
  4. 2.4 Human Immunodeficiency Virus Type-1 Industry Restraints
3 Competitive Landscape by Company
  1. 3.1 Global Human Immunodeficiency Virus Type-1 Revenue by Company (2021-2026)
  2. 3.2 Global Human Immunodeficiency Virus Type-1 Players Revenue Ranking, 2024 VS 2025 VS 2026
  3. 3.3 Global Human Immunodeficiency Virus Type-1 Key Company Head office and Area Served
  4. 3.4 Global Human Immunodeficiency Virus Type-1 Company, Product Type & Application
  5. 3.5 Global Human Immunodeficiency Virus Type-1 Company Establishment Date
  6. 3.6 Market Competitive Analysis
  7. 3.6.1 Global Human Immunodeficiency Virus Type-1 Market CR5 and HHI
  8. 3.6.2 Global Top 5 and 10 Human Immunodeficiency Virus Type-1 Players Market Share by Revenue in 2025
  9. 3.6.3 2025 Human Immunodeficiency Virus Type-1 Tier 1, Tier 2, and Tier 3
4 Human Immunodeficiency Virus Type-1 Market by Type
  1. 4.1 Global Human Immunodeficiency Virus Type-1 Market Size by Type (2021 VS 2025 VS 2032)
  2. 4.2 Global Human Immunodeficiency Virus Type-1 Market Size by Type (2021-2032)
  3. 4.3 Global Human Immunodeficiency Virus Type-1 Market Size Share by Type (2021-2032)
5 Human Immunodeficiency Virus Type-1 Market by Application
  1. 5.1 Global Human Immunodeficiency Virus Type-1 Market Size by Application (2021 VS 2025 VS 2032)
  2. 5.2 Global Human Immunodeficiency Virus Type-1 Market Size by Application (2021-2032)
  3. 5.3 Global Human Immunodeficiency Virus Type-1 Market Size Share by Application (2021-2032)
6 Company Profiles
  1. 6.1 AstraZeneca
  2. 6.1.1 AstraZeneca Company Information
  3. 6.1.2 AstraZeneca Business Overview
  4. 6.1.3 AstraZeneca Human Immunodeficiency Virus Type-1 Revenue and Gross Margin (US$ Million) & (2021-2026)
  5. 6.1.4 AstraZeneca Human Immunodeficiency Virus Type-1 Product Portfolio
  6. 6.1.5 AstraZeneca Recent Developments
  7. 6.2 Bayer
  8. 6.2.1 Bayer Company Information
  9. 6.2.2 Bayer Business Overview
  10. 6.2.3 Bayer Human Immunodeficiency Virus Type-1 Revenue and Gross Margin (US$ Million) & (2021-2026)
  11. 6.2.4 Bayer Human Immunodeficiency Virus Type-1 Product Portfolio
  12. 6.2.5 Bayer Recent Developments
  13. 6.3 Bristol Myers Squibb
  14. 6.3.1 Bristol Myers Squibb Company Information
  15. 6.3.2 Bristol Myers Squibb Business Overview
  16. 6.3.3 Bristol Myers Squibb Human Immunodeficiency Virus Type-1 Revenue and Gross Margin (US$ Million) & (2021-2026)
  17. 6.3.4 Bristol Myers Squibb Human Immunodeficiency Virus Type-1 Product Portfolio
  18. 6.3.5 Bristol Myers Squibb Recent Developments
  19. 6.4 Merck & Co. Inc.
  20. 6.4.1 Merck & Co. Inc. Company Information
  21. 6.4.2 Merck & Co. Inc. Business Overview
  22. 6.4.3 Merck & Co. Inc. Human Immunodeficiency Virus Type-1 Revenue and Gross Margin (US$ Million) & (2021-2026)
  23. 6.4.4 Merck & Co. Inc. Human Immunodeficiency Virus Type-1 Product Portfolio
  24. 6.4.5 Merck & Co. Inc. Recent Developments
  25. 6.5 Novartis
  26. 6.5.1 Novartis Company Information
  27. 6.5.2 Novartis Business Overview
  28. 6.5.3 Novartis Human Immunodeficiency Virus Type-1 Revenue and Gross Margin (US$ Million) & (2021-2026)
  29. 6.5.4 Novartis Human Immunodeficiency Virus Type-1 Product Portfolio
  30. 6.5.5 Novartis Recent Developments
  31. 6.6 Pfizer
  32. 6.6.1 Pfizer Company Information
  33. 6.6.2 Pfizer Business Overview
  34. 6.6.3 Pfizer Human Immunodeficiency Virus Type-1 Revenue and Gross Margin (US$ Million) & (2021-2026)
  35. 6.6.4 Pfizer Human Immunodeficiency Virus Type-1 Product Portfolio
  36. 6.6.5 Pfizer Recent Developments
  37. 6.7 Viatris
  38. 6.7.1 Viatris Company Information
  39. 6.7.2 Viatris Business Overview
  40. 6.7.3 Viatris Human Immunodeficiency Virus Type-1 Revenue and Gross Margin (US$ Million) & (2021-2026)
  41. 6.7.4 Viatris Human Immunodeficiency Virus Type-1 Product Portfolio
  42. 6.7.5 Viatris Recent Developments
  43. 6.8 GSK
  44. 6.8.1 GSK Company Information
  45. 6.8.2 GSK Business Overview
  46. 6.8.3 GSK Human Immunodeficiency Virus Type-1 Revenue and Gross Margin (US$ Million) & (2021-2026)
  47. 6.8.4 GSK Human Immunodeficiency Virus Type-1 Product Portfolio
  48. 6.8.5 GSK Recent Developments
  49. 6.9 Roche
  50. 6.9.1 Roche Company Information
  51. 6.9.2 Roche Business Overview
  52. 6.9.3 Roche Human Immunodeficiency Virus Type-1 Revenue and Gross Margin (US$ Million) & (2021-2026)
  53. 6.9.4 Roche Human Immunodeficiency Virus Type-1 Product Portfolio
  54. 6.9.5 Roche Recent Developments
  55. 6.10 Sanofi
  56. 6.10.1 Sanofi Company Information
  57. 6.10.2 Sanofi Business Overview
  58. 6.10.3 Sanofi Human Immunodeficiency Virus Type-1 Revenue and Gross Margin (US$ Million) & (2021-2026)
  59. 6.10.4 Sanofi Human Immunodeficiency Virus Type-1 Product Portfolio
  60. 6.10.5 Sanofi Recent Developments
7 North America
  1. 7.1 North America Human Immunodeficiency Virus Type-1 Market Size (2021-2032)
  2. 7.2 North America Human Immunodeficiency Virus Type-1 Market Size by Type
  3. 7.2.1 North America Human Immunodeficiency Virus Type-1 Market Size by Type (2021-2026)
  4. 7.2.2 North America Human Immunodeficiency Virus Type-1 Market Size by Type (2027-2032)
  5. 7.2.3 North America Human Immunodeficiency Virus Type-1 Market Share by Type (2021-2032)
  6. 7.3 North America Human Immunodeficiency Virus Type-1 Market Size by Application
  7. 7.3.1 North America Human Immunodeficiency Virus Type-1 Market Size by Application (2021-2026)
  8. 7.3.2 North America Human Immunodeficiency Virus Type-1 Market Size by Application (2027-2032)
  9. 7.3.3 North America Human Immunodeficiency Virus Type-1 Market Share by Application (2021-2032)
  10. 7.4 North America Human Immunodeficiency Virus Type-1 Market Size by Country
  11. 7.4.1 North America Human Immunodeficiency Virus Type-1 Market Size by Country (2021 VS 2025 VS 2032)
  12. 7.4.2 North America Human Immunodeficiency Virus Type-1 Market Size by Country (2021-2026)
  13. 7.4.3 North America Human Immunodeficiency Virus Type-1 Market Size by Country (2027-2032)
  14. 7.4.4 North America Human Immunodeficiency Virus Type-1 Market Share by Country (2021-2032)
  15. 7.4.5 United States
  16. 7.4.6 Canada
  17. 7.4.7 Mexico
8 Europe
  1. 8.1 Europe Human Immunodeficiency Virus Type-1 Market Size (2021-2032)
  2. 8.2 Europe Human Immunodeficiency Virus Type-1 Market Size by Type
  3. 8.2.1 Europe Human Immunodeficiency Virus Type-1 Market Size by Type (2021-2026)
  4. 8.2.2 Europe Human Immunodeficiency Virus Type-1 Market Size by Type (2027-2032)
  5. 8.2.3 Europe Human Immunodeficiency Virus Type-1 Market Share by Type (2021-2032)
  6. 8.3 Europe Human Immunodeficiency Virus Type-1 Market Size by Application
  7. 8.3.1 Europe Human Immunodeficiency Virus Type-1 Market Size by Application (2021-2026)
  8. 8.3.2 Europe Human Immunodeficiency Virus Type-1 Market Size by Application (2027-2032)
  9. 8.3.3 Europe Human Immunodeficiency Virus Type-1 Market Share by Application (2021-2032)
  10. 8.4 Europe Human Immunodeficiency Virus Type-1 Market Size by Country
  11. 8.4.1 Europe Human Immunodeficiency Virus Type-1 Market Size by Country (2021 VS 2025 VS 2032)
  12. 8.4.2 Europe Human Immunodeficiency Virus Type-1 Market Size by Country (2021-2026)
  13. 8.4.3 Europe Human Immunodeficiency Virus Type-1 Market Size by Country (2027-2032)
  14. 8.4.4 Europe Human Immunodeficiency Virus Type-1 Market Share by Country (2021-2032)
  15. 8.4.5 Germany
  16. 8.4.6 France
  17. 8.4.7 U.K.
  18. 8.4.8 Italy
  19. 8.4.9 Russia
  20. 8.4.10 Nordic Countries
9 China
  1. 9.1 China Human Immunodeficiency Virus Type-1 Market Size (2021-2032)
  2. 9.2 China Human Immunodeficiency Virus Type-1 Market Size by Type
  3. 9.2.1 China Human Immunodeficiency Virus Type-1 Market Size by Type (2021-2026)
  4. 9.2.2 China Human Immunodeficiency Virus Type-1 Market Size by Type (2027-2032)
  5. 9.2.3 China Human Immunodeficiency Virus Type-1 Market Share by Type (2021-2032)
  6. 9.3 China Human Immunodeficiency Virus Type-1 Market Size by Application
  7. 9.3.1 China Human Immunodeficiency Virus Type-1 Market Size by Application (2021-2026)
  8. 9.3.2 China Human Immunodeficiency Virus Type-1 Market Size by Application (2027-2032)
  9. 9.3.3 China Human Immunodeficiency Virus Type-1 Market Share by Application (2021-2032)
10 Asia (Excluding China)
  1. 10.1 Asia Human Immunodeficiency Virus Type-1 Market Size (2021-2032)
  2. 10.2 Asia Human Immunodeficiency Virus Type-1 Market Size by Type
  3. 10.2.1 Asia Human Immunodeficiency Virus Type-1 Market Size by Type (2021-2026)
  4. 10.2.2 Asia Human Immunodeficiency Virus Type-1 Market Size by Type (2027-2032)
  5. 10.2.3 Asia Human Immunodeficiency Virus Type-1 Market Share by Type (2021-2032)
  6. 10.3 Asia Human Immunodeficiency Virus Type-1 Market Size by Application
  7. 10.3.1 Asia Human Immunodeficiency Virus Type-1 Market Size by Application (2021-2026)
  8. 10.3.2 Asia Human Immunodeficiency Virus Type-1 Market Size by Application (2027-2032)
  9. 10.3.3 Asia Human Immunodeficiency Virus Type-1 Market Share by Application (2021-2032)
  10. 10.4 Asia Human Immunodeficiency Virus Type-1 Market Size by Country
  11. 10.4.1 Asia Human Immunodeficiency Virus Type-1 Market Size by Country (2021 VS 2025 VS 2032)
  12. 10.4.2 Asia Human Immunodeficiency Virus Type-1 Market Size by Country (2021-2026)
  13. 10.4.3 Asia Human Immunodeficiency Virus Type-1 Market Size by Country (2027-2032)
  14. 10.4.4 Asia Human Immunodeficiency Virus Type-1 Market Share by Country (2021-2032)
  15. 10.4.5 Japan
  16. 10.4.6 South Korea
  17. 10.4.7 Taiwan
  18. 10.4.8 Southeast Asia
  19. 10.4.9 India
  20. 10.4.10 Australia
11 South America, Middle East & Africa
  1. 11.1 South America, Middle East & Africa Human Immunodeficiency Virus Type-1 Market Size (2021-2032)
  2. 11.2 South America, Middle East & Africa Human Immunodeficiency Virus Type-1 Market Size by Type
  3. 11.2.1 South America, Middle East & Africa Human Immunodeficiency Virus Type-1 Market Size by Type (2021-2026)
  4. 11.2.2 South America, Middle East & Africa Human Immunodeficiency Virus Type-1 Market Size by Type (2027-2032)
  5. 11.2.3 South America, Middle East & Africa Human Immunodeficiency Virus Type-1 Market Share by Type (2021-2032)
  6. 11.3 South America, Middle East & Africa Human Immunodeficiency Virus Type-1 Market Size by Application
  7. 11.3.1 South America, Middle East & Africa Human Immunodeficiency Virus Type-1 Market Size by Application (2021-2026)
  8. 11.3.2 South America, Middle East & Africa Human Immunodeficiency Virus Type-1 Market Size by Application (2027-2032)
  9. 11.3.3 South America, Middle East & Africa Human Immunodeficiency Virus Type-1 Market Share by Application (2021-2032)
  10. 11.4 South America, Middle East & Africa Human Immunodeficiency Virus Type-1 Market Size by Country
  11. 11.4.1 South America, Middle East & Africa Human Immunodeficiency Virus Type-1 Market Size by Country (2021 VS 2025 VS 2032)
  12. 11.4.2 South America, Middle East & Africa Human Immunodeficiency Virus Type-1 Market Size by Country (2021-2026)
  13. 11.4.3 South America, Middle East & Africa Human Immunodeficiency Virus Type-1 Market Size by Country (2027-2032)
  14. 11.4.4 South America, Middle East & Africa Human Immunodeficiency Virus Type-1 Market Share by Country (2021-2032)
  15. 11.4.5 Brazil
  16. 11.4.6 South Africa
  17. 11.4.7 Saudi Arabia
  18. 11.4.8 Turkey
  19. 11.4.9 Argentina
  20. 11.4.9 UAE
  21. 11.4.9 Egypt
  22. 11.4.9 Chile
12 Concluding Insights
    13 Appendix
    1. 13.1 Reasons for Doing This Study
    2. 13.2 Research Methodology
    3. 13.3 Research Process
    4. 13.4 Authors List of This Report
    5. 13.5 Data Source
    6. 13.5.1 Secondary Sources
    7. 13.5.2 Primary Sources
    8. 13.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst